PubMed ID: 27448832 Author(s): Domalpally A, Danis R, Agrón E, Blodi B, Clemons T, Chew E; Age-Related Eye Disease Study 2 Research Group. Evaluation of geographic atrophy from color photographs and fundus autofluorescence images: Age-Related …
WRC
WRC
SCORE2 Report 1: Techniques to Optimize Recruitment in Phase III Clinical Trials of Patients With Central Retinal Vein Occlusion.
PubMed ID: 27450625 Author(s): Scott IU, VanVeldhuisen PC, Ip MS, Blodi BA, Oden NL, Figueroa M; SCORE2 Investigator Group. SCORE2 report 1: techniques to optimize recruitment in Phase III clinical trials of patients with central …
Evaluating the Validity of the Age-Related Eye Disease Study Grading Scale for Age-Related Macular Degeneration: AREDS2 Report 10.
PubMed ID: 27442263 Author(s): Vitale S, Clemons TE, Agrón E, Ferris FL 3rd, Domalpally A, Danis RP, Chew EY; Age-Related Eye Disease Study 2 (AREDS2) Research Group. Evaluating the validity of the Age-Related Eye Disease …
Cataract Surgery Outcomes in Uveitis: The Multicenter Uveitis Steroid Treatment Trial.
PubMed ID: 26499920 Author(s): Sen HN, Abreu FM, Louis TA, Sugar EA, Altaweel MM, Elner SG, Holbrook JT, Jabs DA, Kim RY, Kempen JH; Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study Research Group. …
C-reactive protein and diabetic retinopathy in Chinese patients with type 2 diabetes mellitus.
PubMed ID: 26949620 Author(s): Yang XF, Deng Y, Gu H, Lim A, Snellingen T, Liu XP, Wang NL, Domalpally A, Danis R, Liu NP. C-reactive protein and diabetic retinopathy in Chinese patients with type 2 …
Factors Predicting Visual Acuity Outcome in Intermediate, Posterior, and Panuveitis: The Multicenter Uveitis Steroid Treatment (MUST) Trial.
PubMed ID: 26386159 Author(s): Kempen JH, Van Natta ML, Altaweel MM, Dunn JP, Jabs DA, Lightman SL, Thorne JE, Holbrook JT; Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group. Factors predicting visual acuity outcome in …
Joint Associations of Diet, Lifestyle, and Genes with Age-Related Macular Degeneration.
PubMed ID: 26354764 Author(s): Meyers KJ, Liu Z, Millen AE, Iyengar SK, Blodi BA, Johnson E, Snodderly DM, Klein ML, Gehrs KM, Tinker L, Sarto GE, Robinson J, Wallace RB, Mares JA. Joint associations of …
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
PubMed ID: 26298715 Author(s): Multicenter Uveitis Steroid Treatment (MUST) Trial Research Group, Kempen JH, Altaweel MM, Drye LT, Holbrook JT, Jabs DA, Sugar EA, Thorne JE. Benefits of systemic anti-inflammatory therapy versus fluocinolone acetonide intraocular …
Incidence, Risk Factors, and Timing of Elevated Intraocular Pressure After Intravitreal Triamcinolone Acetonide Injection for Macular Edema Secondary to Retinal Vein Occlusion: SCORE Study Report 15.
PubMed ID: 26086920 Author(s): Aref AA, Scott IU, Oden NL, Ip MS, Blodi BA, VanVeldhuisen PC; SCORE Study Investigator Group. Incidence, risk factors, and timing of elevated intraocular pressure after intravitreal triamcinolone acetonide injection for …